• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSE1L 与 MSH6 的相互作用促进骨肉瘤的进展并预测患者预后不良。

CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.

机构信息

Department of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.

出版信息

Sci Rep. 2017 Apr 7;7:46238. doi: 10.1038/srep46238.

DOI:10.1038/srep46238
PMID:28387323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5384328/
Abstract

To discover tumor-associated proteins in osteosarcoma, a quantitative proteomic analysis was performed to identify proteins that were differentially expressed between osteosarcoma and human osteoblastic cells. Through clinical screening and a functional evaluation, chromosome segregation 1-like (CSE1L) protein was found to be related to the growth of osteosarcoma cells. To date, little is known about the function and underlying mechanism of CSE1L in osteosarcoma. In the present study, we show that knockdown of CSE1L inhibits osteosarcoma growth in vitro and in vivo. By co-immunoprecipitation and RNA-seq analysis, CSE1L was found to interact with mutS homolog 6 (MSH6) and function as a positive regulator of MSH6 protein in osteosarcoma cells. A rescue study showed that decreased growth of osteosarcoma cells by CSE1L knockdown was reversed by MSH6 overexpression, indicating that the activity of CSE1L was an MSH6-dependent function. In addition, depletion of MSH6 hindered cellular proliferation in vitro and in vivo. Notably, CSE1L expression was correlated with MSH6 expression in tumor samples and was associated with poor prognosis in patients with osteosarcoma. Taken together, our results demonstrate that the CSE1L-MSH6 axis has an important role in osteosarcoma progression.

摘要

为了在骨肉瘤中发现肿瘤相关蛋白,我们进行了定量蛋白质组学分析,以鉴定在骨肉瘤和人成骨细胞之间差异表达的蛋白。通过临床筛选和功能评估,发现染色体分离 1 样蛋白(CSE1L)与骨肉瘤细胞的生长有关。迄今为止,关于 CSE1L 在骨肉瘤中的功能和潜在机制知之甚少。在本研究中,我们表明 CSE1L 的敲低抑制了骨肉瘤在体外和体内的生长。通过共免疫沉淀和 RNA-seq 分析,发现 CSE1L 与 mutS 同源物 6(MSH6)相互作用,并在骨肉瘤细胞中作为 MSH6 蛋白的正调节剂发挥作用。挽救研究表明,通过 CSE1L 敲低降低骨肉瘤细胞的生长被 MSH6 过表达逆转,表明 CSE1L 的活性是一种依赖于 MSH6 的功能。此外,MSH6 的耗竭抑制了体外和体内的细胞增殖。值得注意的是,CSE1L 表达与肿瘤样本中 MSH6 表达相关,并与骨肉瘤患者的不良预后相关。总之,我们的结果表明 CSE1L-MSH6 轴在骨肉瘤进展中具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/c9bda7d7a5ae/srep46238-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/c1eef700b97e/srep46238-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/331c7d0686a3/srep46238-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/a011c87f25db/srep46238-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/68520b912744/srep46238-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/ba52621736c6/srep46238-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/c9bda7d7a5ae/srep46238-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/c1eef700b97e/srep46238-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/331c7d0686a3/srep46238-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/a011c87f25db/srep46238-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/68520b912744/srep46238-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/ba52621736c6/srep46238-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adff/5384328/c9bda7d7a5ae/srep46238-f6.jpg

相似文献

1
CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.CSE1L 与 MSH6 的相互作用促进骨肉瘤的进展并预测患者预后不良。
Sci Rep. 2017 Apr 7;7:46238. doi: 10.1038/srep46238.
2
Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.微小染色体维持蛋白2和3通过DHX9促进骨肉瘤进展并预示患者预后不良。
Oncotarget. 2017 Apr 18;8(16):26380-26393. doi: 10.18632/oncotarget.15474.
3
CNOT1 cooperates with LMNA to aggravate osteosarcoma tumorigenesis through the Hedgehog signaling pathway.CNOT1 通过 Hedgehog 信号通路与 LMNA 合作加重骨肉瘤的肿瘤发生。
Mol Oncol. 2017 Apr;11(4):388-404. doi: 10.1002/1878-0261.12043. Epub 2017 Mar 6.
4
Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.X盒结合蛋白1(XBP1)的过表达与人类骨肉瘤的不良预后及PI3K/mTOR的上调相关。
Int J Mol Sci. 2015 Dec 2;16(12):28635-46. doi: 10.3390/ijms161226123.
5
Expression of MSH2 and MSH6 on a tissue microarray in patients with osteosarcoma.在骨肉瘤患者的组织微阵列上表达 MSH2 和 MSH6。
Anticancer Res. 2014 Dec;34(12):6961-72.
6
Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.沉默 MSH6 基因联合顺铂对人骨肉瘤细胞株 MG63 增殖的抑制作用。
J Cell Physiol. 2019 Jun;234(6):9358-9369. doi: 10.1002/jcp.27620. Epub 2018 Nov 19.
7
XB130 expression in human osteosarcoma: a clinical and experimental study.XB130在人骨肉瘤中的表达:一项临床与实验研究。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):2565-73. eCollection 2015.
8
TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.TRIM14 通过促进 AKT 信号通路调节骨肉瘤细胞的增殖和侵袭。
Sci Rep. 2017 Feb 16;7:42411. doi: 10.1038/srep42411.
9
LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.长链非编码 RNA WWOX-AS1 抑制骨肉瘤细胞的增殖、迁移和侵袭。
Mol Med Rep. 2018 Jul;18(1):779-788. doi: 10.3892/mmr.2018.9058. Epub 2018 May 23.
10
Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.敲低结直肠癌中的CSE1L基因可降低体外肿瘤发生。
Am J Pathol. 2016 Oct;186(10):2761-8. doi: 10.1016/j.ajpath.2016.06.016. Epub 2016 Aug 10.

引用本文的文献

1
Integrated transcriptome analysis of CSE1L regarding poor prognosis and immune infiltration in bladder urothelial carcinoma and experimental verification.CSE1L 整体转录组分析与膀胱癌不良预后和免疫浸润的关系及实验验证。
Front Immunol. 2024 Oct 4;15:1449251. doi: 10.3389/fimmu.2024.1449251. eCollection 2024.
2
Exosomal CTCF Confers Cisplatin Resistance in Osteosarcoma by Promoting Autophagy the IGF2-AS/miR-579-3p/MSH6 Axis.外泌体CTCF通过促进自噬的IGF2-AS/miR-579-3p/MSH6轴赋予骨肉瘤顺铂耐药性。
J Oncol. 2022 May 31;2022:9390611. doi: 10.1155/2022/9390611. eCollection 2022.
3
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.

本文引用的文献

1
Microtubule actin cross-linking factor 1, a novel target in glioblastoma.微管肌动蛋白交联因子1,胶质母细胞瘤中的一个新靶点。
Int J Oncol. 2017 Jan;50(1):310-316. doi: 10.3892/ijo.2016.3798. Epub 2016 Dec 9.
2
CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.肿瘤进展中的CAS(CSE1L)信号通路及其作为生物标志物和靶向治疗靶点的潜力。
Tumour Biol. 2016 Oct;37(10):13077-13090. doi: 10.1007/s13277-016-5301-x. Epub 2016 Sep 5.
3
Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
丁酸盐补充剂调节染色体分离 1 样蛋白的表达,以逆转结直肠癌中 p53 突变引起的遗传畸变。
Int J Oncol. 2022 Jun;60(6). doi: 10.3892/ijo.2022.5354. Epub 2022 Apr 13.
4
CSE1L silencing impairs tumor progression via MET/STAT3/PD-L1 signaling in lung cancer.CSE1L基因沉默通过肺癌中的MET/STAT3/PD-L1信号通路损害肿瘤进展。
Am J Cancer Res. 2021 Sep 15;11(9):4380-4393. eCollection 2021.
5
Nuclear export protein CSE1L interacts with P65 and promotes NSCLC growth via NF-κB/MAPK pathway.核输出蛋白CSE1L与P65相互作用并通过NF-κB/MAPK途径促进非小细胞肺癌生长。
Mol Ther Oncolytics. 2021 Mar 10;21:23-36. doi: 10.1016/j.omto.2021.02.015. eCollection 2021 Jun 25.
6
CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway.CSE1L作为一种新型预后标志物,通过调节AKT/mTOR信号通路促进胰腺癌增殖。
J Cancer. 2021 Mar 14;12(10):2797-2806. doi: 10.7150/jca.54482. eCollection 2021.
7
Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma.基于五个与分期相关基因和TNM分期的综合列线图预测肝细胞癌1年复发情况
Cancer Cell Int. 2020 Apr 29;20:140. doi: 10.1186/s12935-020-01216-9. eCollection 2020.
8
Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1.细胞凋亡敏感性蛋白(CAS)通过上调 CYP24A1 抑制乳腺癌细胞的增殖。
Med Oncol. 2020 Apr 8;37(5):43. doi: 10.1007/s12032-020-01366-w.
9
Ewing-like sarcoma/undifferentiated round cell sarcoma in an infant with APC and MSH6 variation: A case report.伴有APC和MSH6变异的婴儿尤因样肉瘤/未分化圆形细胞肉瘤:一例报告
Medicine (Baltimore). 2019 Nov;98(45):e17872. doi: 10.1097/MD.0000000000017872.
10
The role of CSE1L expression in cervical lymph node metastasis of larynx tumors.CSE1L 表达在喉肿瘤颈部淋巴结转移中的作用。
Braz J Otorhinolaryngol. 2021 Jan-Feb;87(1):42-46. doi: 10.1016/j.bjorl.2019.06.010. Epub 2019 Jul 24.
敲低结直肠癌中的CSE1L基因可降低体外肿瘤发生。
Am J Pathol. 2016 Oct;186(10):2761-8. doi: 10.1016/j.ajpath.2016.06.016. Epub 2016 Aug 10.
4
Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder.硫化氢及其合成酶的表达谱与膀胱尿路上皮细胞癌的肿瘤分期和分级相关。
Urol Oncol. 2016 Apr;34(4):166.e15-20. doi: 10.1016/j.urolonc.2015.06.020. Epub 2016 Feb 1.
5
Downregulation of IDH2 exacerbates the malignant progression of osteosarcoma cells via increased NF-κB and MMP-9 activation.异柠檬酸脱氢酶2(IDH2)的下调通过增强核因子κB(NF-κB)和基质金属蛋白酶-9(MMP-9)的激活来加剧骨肉瘤细胞的恶性进展。
Oncol Rep. 2016 Apr;35(4):2277-85. doi: 10.3892/or.2016.4553. Epub 2016 Jan 13.
6
Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.两种脂质代谢酶HADHA和ACAT2在透明细胞肾细胞癌中的预后意义
Tumour Biol. 2016 Jun;37(6):8121-30. doi: 10.1007/s13277-015-4720-4. Epub 2015 Dec 29.
7
A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells.人骨肉瘤U2OS细胞中SRSF3调控的剪接事件和基因表达的基因组图谱。
Nucleic Acids Res. 2016 Feb 29;44(4):1854-70. doi: 10.1093/nar/gkv1500. Epub 2015 Dec 23.
8
Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma.凝溶胶蛋白通过上调骨肉瘤中的p-AKT和p-P38通路来促进细胞生长和侵袭。
Tumour Biol. 2016 Jun;37(6):7165-74. doi: 10.1007/s13277-015-4565-x. Epub 2015 Dec 12.
9
Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.TSTA3在乳腺癌中的致癌潜力及其受肿瘤抑制因子miR-125a-5p和miR-125b的调控
Tumour Biol. 2016 Apr;37(4):4963-72. doi: 10.1007/s13277-015-4178-4. Epub 2015 Nov 3.
10
MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.微小RNA-542-5p是一种负性预后因素,通过靶向HUWE1促进骨肉瘤的肿瘤发生。
Oncotarget. 2015 Dec 15;6(40):42761-72. doi: 10.18632/oncotarget.6199.